Transapical Implantation of the Medtronic Engager Transcatheter Aortic Valve Implantation System - The Engager European Pivotal Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 125 participants.
Also called NCT01348438
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 125 participants
- Registry
-
NCT01348438
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Germany, Israel, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT01348438. Allocation not applicable; no masking; primary purpose treatment. Start 2011-09-12 (actual); primary completion 2013-02-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Transapical Implantation of the Medtronic Engager Transcatheter Aortic Valve Implantation System - The Engager European Pivotal Trial
- Condition
- Aortic Valve Stenosis
- Intervention (Device)
- Medtronic Engager Transcatheter Aortic Valve Implantation System
- Lead sponsor
- Medtronic Cardiac Rhythm and Heart Failure
Record details
- Record id
cardio:ct-nct01348438- Content hash
5db8d526bc38ce7efaab139e53b7b3b6ff749c8e8aab0b883b6369f22635752f